Select Publications
Book Chapters
2021, 'Repairing cardiac allografts on ex situ perfusion devices', in Organ Repair and Regeneration: Preserving Organs in the Regenerative Medicine Era, pp. 213 - 230, http://dx.doi.org/10.1016/B978-0-12-819451-5.00010-X
,2019, 'Haemodynamic evaluation of the heart transplant patient', in Interventional Cardiology and Cardiac Catheterisation, CRC Press, pp. 417 - 425, http://dx.doi.org/10.1201/9781351060356-29
,2018, 'HFrEF other treatment: transplantation', in ESC CardioMed, Oxford University Press, pp. 1889 - 1892, http://dx.doi.org/10.1093/med/9780198784906.003.0433
,2013, 'Assessment, monitoring, and management of brain-dead potential organ donors in Australia', in The Brain-Dead Organ Donor: Pathophysiology and Management, pp. 237 - 249, http://dx.doi.org/10.1007/978-1-4614-4304-9_19
,2013, 'Heart and lung transplantation', in Oh's Intensive Care Manual, Seventh Edition, pp. 1053 - 1067, http://dx.doi.org/10.1016/B978-0-7020-4762-6.00102-8
,2011, 'Dyspnoea', in Supportive Care in Heart Failure, http://dx.doi.org/10.1093/acprof:oso/9780198570288.003.0009
,2008, 'Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases', in Clinical Proteomics: From Diagnosis to Therapy, pp. 571 - 592, http://dx.doi.org/10.1002/9783527622153.ch31
,2008, 'Actin and Its Binding Proteins in Heart Failure', in Actin-Binding Proteins and Disease, Springer New York, pp. 318 - 334, http://dx.doi.org/10.1007/978-0-387-71749-4_14
,1998, 'Increased Nitric Oxide Production in Heart Failure and Correlation with Functional Severity', in Vascular Endothelium, Springer US, pp. 283 - 284, http://dx.doi.org/10.1007/978-1-4899-0133-0_43
,1998, 'The Role of Nitric Oxide Production during Cardiac Allograft Rejection', in Vascular Endothelium, Springer US, pp. 281 - 282, http://dx.doi.org/10.1007/978-1-4899-0133-0_42
,Journal articles
2024, 'Retinal microvascular remodeling associates with adverse events in continuous-flow left ventricular assist device-supported patients', Journal of Heart and Lung Transplantation, 43, pp. 1975 - 1984, http://dx.doi.org/10.1016/j.healun.2024.07.017
,2024, 'Renal resistive index in patients supported with a durable continuous flow left ventricular assist device', Artificial Organs, 48, pp. 1366 - 1371, http://dx.doi.org/10.1111/aor.14854
,2024, 'Using an Isolated Working Rat Heart Model to Test Donor Heart Preservation Strategies', Journal of visualized experiments : JoVE, http://dx.doi.org/10.3791/66910
,2024, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, 30, pp. 1481 - 1486, http://dx.doi.org/10.1177/1357633X231151714
,2024, 'Dietary Sodium Intake and Outcomes: a Secondary Analysis From Sodium-HF', Journal of Cardiac Failure, 30, pp. 1073 - 1082, http://dx.doi.org/10.1016/j.cardfail.2024.04.031
,2024, 'Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System', Heart Lung and Circulation, 33, pp. 1173 - 1183, http://dx.doi.org/10.1016/j.hlc.2024.03.004
,2024, 'Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival', American Journal of Transplantation, 24, pp. 1414 - 1426, http://dx.doi.org/10.1016/j.ajt.2024.03.031
,2024, 'Reduction in pacemaker rates post-heart transplantation with use of organ preservation systems', Europace, 26, http://dx.doi.org/10.1093/europace/euae102.387
,2024, 'Utilizing Quality of Life Adjusted Days Alive and out of Hospital in Heart Failure Clinical Trials', Circulation: Cardiovascular Quality and Outcomes, 17, pp. E010560, http://dx.doi.org/10.1161/CIRCOUTCOMES.123.010560
,2024, 'The Relationship Between Rehabilitation and Frailty in Advanced Heart or Lung Disease', Transplantation Direct, 10, pp. E1606, http://dx.doi.org/10.1097/TXD.0000000000001606
,2024, 'Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial', Journal of Heart and Lung Transplantation, 43, pp. 485 - 495, http://dx.doi.org/10.1016/j.healun.2023.10.020
,2024, 'Molecular states associated with dysfunction and graft loss in heart transplants', Journal of Heart and Lung Transplantation, 43, pp. 508 - 518, http://dx.doi.org/10.1016/j.healun.2023.11.013
,2024, 'Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It', Transplantation, 108, pp. 662 - 668, http://dx.doi.org/10.1097/TP.0000000000004740
,2024, 'Severe Acute Kidney Injury Postheart Transplantation: Analysis of Risk Factors', Transplantation Direct, 10, pp. E1585, http://dx.doi.org/10.1097/TXD.0000000000001585
,2024, 'Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort', Journal of Heart and Lung Transplantation, 43, pp. 346 - 349, http://dx.doi.org/10.1016/j.healun.2023.09.007
,2024, 'Simultaneous Heart and Kidney Transplantation for LVAD-supported Patients with Chronic Kidney Disease?', Transplantation, 108, pp. 331 - 332, http://dx.doi.org/10.1097/TP.0000000000004782
,2024, 'Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement', Journal of Heart and Lung Transplantation, 43, pp. 1 - 27, http://dx.doi.org/10.1016/j.healun.2023.09.013
,2024, 'Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients', Transplantation, http://dx.doi.org/10.1097/TP.0000000000005131
,2024, 'Machine Perfusion of Donor Hearts – The Recovery and Transplantation of Previously Unrecoverable Hearts', OBM Transplantation, 8, pp. 1 - 20, http://dx.doi.org/10.21926/obm.transplant.2403222
,2024, 'The Rapidly Evolving Landscape of DCD Heart Transplantation', Current Cardiology Reports, http://dx.doi.org/10.1007/s11886-024-02148-w
,2024, 'The search continues: Investigating potential biomarkers to predict cardiac allograft function from donation after circulatory death donors', Journal of Heart and Lung Transplantation, http://dx.doi.org/10.1016/j.healun.2024.09.017
,2024, 'Using pulsatility responses to breath-hold maneuvers to predict readmission rates in continuous-flow left ventricular assist device patients', Artificial Organs, 48, pp. 70 - 82, http://dx.doi.org/10.1111/aor.14644
,2024, 'A Retrospective Audit of the Relationship Between Rehabilitation and Frailty in Advanced Heart or Lung Disease', The Journal of Heart and Lung Transplantation, 43, pp. S512 - S512, http://dx.doi.org/10.1016/j.healun.2024.02.719
,2024, 'Case Series of Large Animal Implants of the BiVACOR Total Artificial Heart', Heart, Lung and Circulation, 33, pp. S35 - S35, http://dx.doi.org/10.1016/j.hlc.2024.04.096
,2024, 'Coronary Revascularisation for Patients With Obstructive Coronary Artery Disease Requiring Lung Transplantation', Heart, Lung and Circulation, 33, pp. S234 - S235, http://dx.doi.org/10.1016/j.hlc.2024.06.228
,2024, 'Crossing the Turbulent Hepatitis Sea: Use of Prophylactic Glecaprevir/Pibrentasvir to Facilitate Cardiothoracic Transplants from Hepatitis C Viremic Donors in Australia', The Journal of Heart and Lung Transplantation, 43, pp. S452 - S452, http://dx.doi.org/10.1016/j.healun.2024.02.1408
,2024, 'Donation After Circulatory Death Heart Transplantation - Withdrawal Practices and Location Matter!', The Journal of Heart and Lung Transplantation, 43, pp. S123 - S123, http://dx.doi.org/10.1016/j.healun.2024.02.248
,2024, 'Fournier’s gangrene in recent transplant recipient on empagliflozin', JHLT Open, 4, pp. 100060 - 100060, http://dx.doi.org/10.1016/j.jhlto.2024.100060
,2024, 'Genome-Wide Molecular Analysis of Heart Transplant Endomyocardial Biopsies Separately Analyzing Rejection and Parenchymal Injury', The Journal of Heart and Lung Transplantation, 43, pp. S43 - S43, http://dx.doi.org/10.1016/j.healun.2024.02.085
,2024, 'High-Grade Eosinophils on Diagnostic Transbronchial Biopsy are Associated with Chronic Lung Allograft Dysfunction After Lung Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S294 - S294, http://dx.doi.org/10.1016/j.healun.2024.02.419
,2024, 'Investigating Pharmacological Cardioprotective Strategies', Heart, Lung and Circulation, 33, pp. S4 - S5, http://dx.doi.org/10.1016/j.hlc.2024.04.014
,2024, 'Never Too Old to Join the Pool - Heart Transplantation From Older Donation After Circulatory Death Donors in Australia', The Journal of Heart and Lung Transplantation, 43, pp. S122 - S122, http://dx.doi.org/10.1016/j.healun.2024.02.245
,2024, 'Transitions Between Molecular Rejection Classes in Heart Endomyocardial Biopsies', The Journal of Heart and Lung Transplantation, 43, pp. S375 - S375, http://dx.doi.org/10.1016/j.healun.2024.02.601
,2023, 'Advances in cardiac machine perfusion: Exceeding 8 hours from procurement to implant without requiring extracorporeal membrane oxygenation', Journal of Heart and Lung Transplantation, 42, pp. 1766 - 1767, http://dx.doi.org/10.1016/j.healun.2023.08.003
,2023, 'Heart Transplantation from DCD Donors Enters the Mainstream', Transplantation, 107, pp. 2449 - 2450, http://dx.doi.org/10.1097/TP.0000000000004761
,2023, 'Major adverse kidney events predict reduced survival in ventricular assist device supported patients', ESC Heart Failure, 10, pp. 3463 - 3471, http://dx.doi.org/10.1002/ehf2.14533
,2023, 'Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices', International Journal of Cardiology, 391, http://dx.doi.org/10.1016/j.ijcard.2023.131259
,2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319
,2023, 'Pulse pressure within the first 2 days of veno-arterial extracorporeal membrane oxygenation is predictive of death prior to hospital discharge, renal dysfunction requiring dialysis and pulmonary oedema', Perfusion (United Kingdom), 38, pp. 1568 - 1576, http://dx.doi.org/10.1177/02676591221115935
,2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733
,